🇺🇸 FDA
Patent

US 8110585

Bicyclic compound and pharmaceutical use thereof

granted A61PA61P1/04A61P11/08

Quick answer

US patent 8110585 (Bicyclic compound and pharmaceutical use thereof) held by Takeda Pharmaceutical Company Limited expires Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Feb 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61P, A61P1/04, A61P11/08, A61P15/00, A61P15/08